Clinical Trial Update: OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy

View source ↗

Summary

A post-marketing clinical registry update in Italy for OncoSil in locally advanced pancreatic adenocarcinoma, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• OncoSil

Snippet

Sponsor: OncoSil Medical Limited | Conditions: Locally Advanced Pancreatic Adenocarcinoma | Status: NOT_YET_RECRUITING